CURRENT PUBLICATIONS (Ranked by Impact Factor of the Journal) Abortive HIV Infection Mediates CD4 T Cell Depletion and Inflammation in Human Lymphoid Tissue In ex vivo cultures of human tonsil tissue, CD4 T cells undergo a pronounced cytopathic response following HIV infection. Strikingly, >95% of these dying cells are not productively infected but instead correspond to bystander cells. Researchers now show that the death of these “bystander” cells involves abortive HIV infection. [Cell] Mzb1 Protein Regulates Calcium Homeostasis, Antibody Secretion, and Integrin Activation in Innate-Like B Cells Marginal zone (MZ) B cells of the spleen and B1 cells, termed innate-like B cells, differ from follicular B cells by their attenuated Ca2+ mobilization, fast antibody secretion, and increased cell adhesion. Researchers identified and characterized Mzb1 as an endoplasmic reticulum-localized and B cell-specific protein that was most abundantly expressed in MZ B and B1 cells. [Immunity] Endogenous Cortisol and TGF-Beta in Human Aqueous Humor Contribute to Ocular Immune Privilege by Regulating Dendritic Cell Function Aqueous humor (AqH) has been shown to have significant immunosuppressive effects on APCs in animal models. Researchers wanted to establish whether, in humans, AqH can regulate dendritic cell function and to identify the dominant mechanism involved. [J Immunol] Distinct Roles for the NK Cell-Activating Receptors in Mediating Interactions with Dendritic Cells and Tumor Cells This study investigates the interaction of NK cells with dendritic cells and tumor cells, and the role of specific NK cell-activating receptors in this process. [J Immunol] Cannabinoid Receptor Activation Leads to Massive Mobilization of Myeloid-Derived Suppressor Cells with Potent Immunosuppressive Properties Here, researchers show that administration of delta9-tetrahydrocannabinol in mice leads to rapid and massive expansion of CD11b(+)Gr-1(+) myeloid-derived suppressor cells expressing functional arginase and exhibiting potent immunosuppressive properties both in vitro and in vivo. [Eur J Immunol] Regulatory T Cells Predict the Time to Initial Treatment in Early Stage Chronic Lymphocytic Leukemia Higher regulatory T cell levels had significant and independent prognostic power for predicting the time to initial treatment in patients with low to intermediate stage chronic lymphocytic leukemia. [Cancer] Overrepresentation of IL-17A and IL-22 Producing CD8 T Cells in Lesional Skin Suggests Their Involvement in the Pathogenesis of Psoriasis By spectral imaging analysis of double-stained skin sections researchers demonstrated that IL-17 was mainly expressed by mast cells and neutrophils and IL-22 by macrophages and dendritic cells. [PLoS ONE] The Canonical BMP Signaling Pathway is Involved in Human Monocyte-Derived Dendritic Cell Maturation In this study, researchers investigate the effects of bone morphogenetic protein signaling activation on the capacity of human dendritic cells to stimulate immune responses. [Immunol Cell Biol]
|
|
EVENTS (Listed by Date) American Association for Cancer Research (AACR) Tumor Immunology – Basic and Clinical Advances November 30-December 3, 2010 Miami, United States Vaccines Europe 2010 December 1-2, 2010 London, United Kingdom Cell Symposia: Influenza – Translating Basic Insights December 2-4, 2010 Washington, D.C., United States 5th Annual Stem Cell Meeting on the Mesa December 7, 2010 La Jolla, United States Safety Symposium organized by the NIH RAC and Co-hosted by CliniGene: Retroviral and Lentiviral Vectors for Long-Term Gene Correction: Clinical Challenges in Vector and Trial Design December 9-10, 2010 Bethesda, United States The 50th Midwinter Conference of Immunologists at Asilomar January 22-25, 2011 Pacific Grove, United States Phacilitate 7th Annual Cell & Gene Therapy Forum 2011 January 24-26, 2011 Washington, D.C., United States Phacilitate 9th Annual North American Vaccine Forum January 24-26, 2011 Washington, D.C., United States AACR-ACS Joint Meeting on Chemistry in Cancer Research: The Biological Chemistry of Inflammation as a Cause of Cancer January 30-February 2, 2011 San Diego, United States Keystone Symposia: Dendritic Cells and the Initiation of Adaptive Immunity February 12-17, 2011 Santa Fe, United States Keystone Symposia: Genetics, Immunology and Repair in Multiple Sclerosis February 15-20, 2011 Taos, United States Lorne Infection and Immunity Conference 2011 February 16-18, 2011 Lorne, Australia 18th Conference on Retroviruses and Opportunistic Infections (CROI 2011) February 27-March 2, 2011 Boston, United States The 6th International Conference on Oncolytic Viruses as Cancer Therapeutics March 16-19, 2011 Las Vegas, United States 2011 American Academy of Allergy, Asthma and Immunology (AAAAI) Annual Meeting March 18-22, 2011 San Francisco, United States Microbiota and Mucosal Immunology: The Interface in Health and Disease April 14-16, 2011 San Francisco, United States GTCbio 2nd International Conference on Cancer Immunotherapy & Immunomonitoring May 2-5, 2011 Budapest, Hungary American Society of Gene and Cell Therapy (ASGCT) 14th Annual Meeting May 18-22, 2011 Seattle, United States Gordon Research Conference: Viruses & Cells May 29-June 3, 2011 Lucca (Barga), Italy DNA Vaccines 2011 July 12-14, 2011 San Diego, United States Visit our events page to stay up to date with the latest events in the cell, gene and immunotherapy community.
JOB OPPORTUNITIES Lab Technologist – Human Embryonic and Induced Pluripotent Stem Cells (STEMCELL Technologies) Lab Technologist – Tissue Culture (STEMCELL Technologies) Product Manager – Pluripotent Stem Cells (STEMCELL Technologies) Recruit Top Talent Reach more than 11,000 potential candidates by posting your organization’s career opportunities with Cell Therapy News at no cost. Visit here to post your career opportunities.
Have we missed an important article or publication in Immune Regulation News? Click here to submit! Comments or Suggestions? Email info@connexoncreative.com with your feedback.
|
| |
|